[HTML][HTML] Bioinformatics analyses of significant genes, related pathways and candidate prognostic biomarkers in glioblastoma
L Zhou, H Tang, F Wang, L Chen… - Molecular …, 2018 - spandidos-publications.com
Glioblastoma (GBM) is the most common type of malignant tumor of the central nervous
system. The prognosis of patients with GBM is very poor, with a survival time of~ 15 months …
system. The prognosis of patients with GBM is very poor, with a survival time of~ 15 months …
[HTML][HTML] Bioinformatics analyses of significant genes, related pathways and candidate prognostic biomarkers in glioblastoma
L Zhou, H Tang, F Wang, L Chen, S Ou… - Molecular Medicine …, 2018 - ncbi.nlm.nih.gov
Glioblastoma (GBM) is the most common type of malignant tumor of the central nervous
system. The prognosis of patients with GBM is very poor, with a survival time of~ 15 months …
system. The prognosis of patients with GBM is very poor, with a survival time of~ 15 months …
[PDF][PDF] Bioinformatics analyses of significant genes, related pathways and candidate prognostic biomarkers in glioblastoma
L ZHOU, HAI TANG, F WANG, L CHEN… - MOLECULAR …, 2018 - academia.edu
Glioblastoma (GBM) is the most common type of malignant tumor of the central nervous
system. The prognosis of patients with GBM is very poor, with a survival time of~ 15 months …
system. The prognosis of patients with GBM is very poor, with a survival time of~ 15 months …
[PDF][PDF] Bioinformatics analyses of significant genes, related pathways and candidate prognostic biomarkers in glioblastoma
L ZHOU, HAI TANG, F WANG… - MOLECULAR …, 2018 - pdfs.semanticscholar.org
Glioblastoma (GBM) is the most common type of malignant tumor of the central nervous
system. The prognosis of patients with GBM is very poor, with a survival time of~ 15 months …
system. The prognosis of patients with GBM is very poor, with a survival time of~ 15 months …
Bioinformatics analyses of significant genes, related pathways and candidate prognostic biomarkers in glioblastoma.
L Zhou, H Tang, F Wang, L Chen, S Ou… - Molecular Medicine …, 2018 - search.ebscohost.com
Glioblastoma (GBM) is the most common type of malignant tumor of the central nervous
system. The prognosis of patients with GBM is very poor, with a survival time of~ 15 months …
system. The prognosis of patients with GBM is very poor, with a survival time of~ 15 months …
Bioinformatics analyses of significant genes, related pathways and candidate prognostic biomarkers in glioblastoma.
L Zhou, H Tang, F Wang, L Chen, S Ou… - Molecular Medicine …, 2018 - europepmc.org
Glioblastoma (GBM) is the most common type of malignant tumor of the central nervous
system. The prognosis of patients with GBM is very poor, with a survival time of~ 15 months …
system. The prognosis of patients with GBM is very poor, with a survival time of~ 15 months …
Bioinformatics analyses of significant genes, related pathways and candidate prognostic biomarkers in glioblastoma
L Zhou, H Tang, F Wang, L Chen, S Ou… - Molecular Medicine …, 2018 - search.proquest.com
Glioblastoma (GBM) is the most common type of malignant tumor of the central nervous
system. The prognosis of patients with GBM is very poor, with a survival time of~ 15 months …
system. The prognosis of patients with GBM is very poor, with a survival time of~ 15 months …
Bioinformatics analyses of significant genes, related pathways and candidate prognostic biomarkers in glioblastoma
L Zhou, H Tang, F Wang, L Chen, S Ou, T Wu… - Molecular Medicine …, 2018 - go.gale.com
Glioblastoma (GBM) is the most common type of malignant tumor of the central nervous
system. The prognosis of patients with GBM is very poor, with a survival time of~ 15 months …
system. The prognosis of patients with GBM is very poor, with a survival time of~ 15 months …
Bioinformatics analyses of significant genes, related pathways and candidate prognostic biomarkers in glioblastoma
L Zhou, H Tang, F Wang, L Chen… - Molecular …, 2018 - pubmed.ncbi.nlm.nih.gov
Glioblastoma (GBM) is the most common type of malignant tumor of the central nervous
system. The prognosis of patients with GBM is very poor, with a survival time of~ 15 months …
system. The prognosis of patients with GBM is very poor, with a survival time of~ 15 months …
[HTML][HTML] Bioinformatics analyses of significant genes, related pathways and candidate prognostic biomarkers in glioblastoma
L Zhou, H Tang, F Wang, L Chen… - Molecular …, 2018 - spandidos-publications.com
Glioblastoma (GBM) is the most common type of malignant tumor of the central nervous
system. The prognosis of patients with GBM is very poor, with a survival time of~ 15 months …
system. The prognosis of patients with GBM is very poor, with a survival time of~ 15 months …